Aligos Therapeutics (ALGS) EBIT Growth (5y) (2024 - 2026)

Aligos Therapeutics (ALGS) EBIT Growth (5y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.92 Bn	131.07 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.91 Bn	77.91 Bn	3.93 Bn
3	Argenx Se	64.87 Bn	59.68 Bn	1.37 Bn
4	Moderna	58.18 Bn	53.04 Bn	52.00 Mn
5	BeOne Medicines	41.96 Bn	36.87 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.53 Bn	28.23 Bn	992.69 Mn
7	BioNTech SE	27.79 Bn	9.40 Bn	668.28 Mn
8	Insmed	27.46 Bn	26.30 Bn	358.27 Mn
9	Royalty Pharma	27.37 Bn	26.53 Bn	-
10	Aligos Therapeutics	68.82 Mn	38.38 Mn	-

Download Data